Birmingham Vasculitis Activity Scores (BVAS) were used to identify disease manifestations. Key efficacy outcomes included remission at week 26, sustained remission at week 52, relapse rates, the ...

Researchers found that use of immunosuppressive medication was a strong protective factor, associated with a 60% reduction in ...

recruited patients newly diagnosed with ANCA-associated disease ... Of the patients who attained remission, 109 (42%) suffered relapse. Lung and upper respiratory tract vascular sclerosis ...